A generic method for design of oligomer-specific antibodies.
Antibodies that preferentially and specifically target pathological oligomeric protein and peptide assemblies, as opposed to their monomeric and amyloid counterparts, provide therapeutic and diagnostic opportunities for protein misfolding diseases. Unfortunately, the molecular properties associated...
Guardado en:
Autores principales: | Kristoffer Brännström, Malin Lindhagen-Persson, Anna L Gharibyan, Irina Iakovleva, Monika Vestling, Mikael E Sellin, Thomas Brännström, Ludmilla Morozova-Roche, Lars Forsgren, Anders Olofsson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/85bdb2aa8c704054b936e00b43b5987b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
por: Malin Lindhagen-Persson, et al.
Publicado: (2010) -
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.
por: Kiran Yanamandra, et al.
Publicado: (2011) -
The Swedish translation and cultural adaptation of the Measure of Moral Distress for Healthcare Professionals (MMD-HP)
por: Catarina Fischer-Grönlund, et al.
Publicado: (2021) -
PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.
por: Mourad Tayebi, et al.
Publicado: (2011) -
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
por: Ebrima Gibbs, et al.
Publicado: (2019)